Influence of UGT1A1 *6/*28 Polymorphisms on Irinotecan-Related Toxicity and Survival in Pediatric Patients with Relapsed/Refractory Solid Tumors Treated with the VIT Regimen

Xiaoqin Zhu,1,2,* Jia Zhu,1,2,* Feifei Sun,1,2,* Zijun Zhen,1,2 Dalei Zhou,1,3 Suying Lu,1,2 Junting Huang,1,2 Yi Que,1,2 Lian Zhang,1,2 Ruiqing Cai,1,2 Juan Wang,1,2 Yizhuo Zhang1,2 1State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen Un...

Descripción completa

Detalles Bibliográficos

Autores principales:	Zhu X, Zhu J, Sun F, Zhen Z, Zhou D, Lu S, Huang J, Que Y, Zhang L, Cai R, Wang J, Zhang Y
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Dove Medical Press 2021-03-01
Colección:	Pharmacogenomics and Personalized Medicine
Materias:	ugt1a1 *6/*28 polymorphism irinotecan toxicity pediatric relapsed/refractory solid tumors
Acceso en línea:	https://www.dovepress.com/influence-of-ugt1a1-628-polymorphisms-on-irinotecan-related-toxicity-a-peer-reviewed-article-PGPM
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!